Reata Pharmaceuticals used patient histories with trials data to win approval for new Friedreich’s ataxia drug

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Florida Republicans propose a 6-week abortion ban

Moments before Gov. Ron DeSantis delivered a highly publicized speech Tuesday morning…

About 5 percent of young adults identify as transgender or nonbinary, U.S. survey finds

Approximately 5 percent of young adults in the U.S. identify as transgender…

Fed Raises Interest Rates by 0.75 Percentage Point

WASHINGTON—The Federal Reserve continued a sprint to reverse its easy-money policies by…

How fighting in southern Gaza may complicate mass evacuations

IE 11 is not supported. For an optimal experience visit our site…